For non-digestive cancers, including non-small cell lung cancer (NSCLC), breast cancer (BC), and glioma, RACK1 is a significant biomarker of poor prognosis (Cao et al., 2010; Lv et al., 2016; Qu et al., 2017). This evidence concerns the gene RACK1 and breast cancer.